In a report released yesterday, Akash Tewari from Jefferies maintained a Buy rating on Pfizer (PFE – Research Report), with a price target of ...
Sales and earnings have plunged since the pandemic ended, sending Pfizer stock down over 50% off its former high. As terrible ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results